Do statins protect against the development of Clostridium difficile-associated diarrhoea?

Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate - a placebo-controlled study

(2012) W. Nseir et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Statin use and the risk ofClostridium difficilein academic medical centres

(2012) Christine Anne Motzkus-Feagans et al.   GUT

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin

(2012) Majed Masadeh et al.   Annals of Clinical Microbiology and Antimicrobials

The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients

(2011) W. Nseir et al.   INFECTION

Long-Term Statin Therapy Affects the Severity of Chronic Gastritis

(2010) William Nseir et al.   HELICOBACTER

Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of NosocomialClostridum difficile–Associated Disease

(2010) Amee R. Manges et al.   JOURNAL OF INFECTIOUS DISEASES

Statins for the Prevention and Treatment of Infections

(2009) Imad M. Tleyjeh   ARCHIVES OF INTERNAL MEDICINE

Clinically important interaction between statin drugs and Clostridium difficile toxin?

(2009) Timothy McGuire et al.   MEDICAL HYPOTHESES